AXXAM
  • Home
  • About Us
    • Company Profile
    • Axxam Philosophy
    • People
    • Facilities
    • Quality and HSE
    • Partners
    • Participated Companies
    • Publications
    • Grants
    • Posters
    • Legislative Decree no. 231/2001
    • Locations
  • Discovery Services
    • Service Overview
    • Biochemical Assays
    • Cell-based Assays
    • Electrophysiology
    • Phenotypic Screening
    • High-Throughput Screening
    • Compound Collections
    • Hit-to-Lead
  • Innovative Biology
    • iPSC Platform
    • Optogenetics
    • Organellar Electrophysiology
    • RNA Biology
    • SARS-CoV-2 Assays
  • Careers
    • Working at Axxam
    • Job Listing
  • News & Events
    • News
    • Events
  • Contact Us
Select Page

Molecular interactions in drug discovery programs

Privacy Policy     Cookie Policy     Disclaimer     info@axxam.com

Subscribe to Axxam Newsletter

  • LinkedIn
  • YouTube
AXXAM S.p.A.- Openzone - Via Meucci, 3 - 20091 Bresso - Milan, Italy - Cap. Soc.: euro 137.477 i.v. - C.F./P.Iva/Vat IT13451210150 - R.E.A. Milan 1653022